New study: People with Diabetes are at Increased Risk of Flu Complications
Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial
High-dose influenza vaccines provide better protection against influenza infection than standard-dose in persons aged 65 years and above.
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
Organismal ageing is associated with many physiological changes, including differences in the immune system of most animals.
Using correlates to accelerate vaccinology
Correlates and surrogates of desired outcomes are valuable but have limitations
Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial
Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes: A Nationwide Cohort Study
Recent influenza infection is associated with an increased risk of atherothrombotic events, including acute myocardial infarction (AMI) and stroke.
Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes
The health burden caused by seasonal influenza is substantial.
